These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Allergen-specific immunotherapy (hyposensitization). Part 1. Basics and subcutaneous application]. Klimek L HNO; 2000 Jan; 48(1):59-67. PubMed ID: 10663053 [No Abstract] [Full Text] [Related]
14. Recombinant allergens for SIT of cat allergy. Meno K Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2013; 97():148-52. PubMed ID: 24912329 [No Abstract] [Full Text] [Related]
15. The efficacy of oromucosal immunotherapy in respiratory allergy. Brown JL; Frew AJ Clin Exp Allergy; 2001 Jan; 31(1):8-10. PubMed ID: 11167944 [No Abstract] [Full Text] [Related]
16. Efficacy and its persistence, in children and adults. Di Rienzo V Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):35-7. PubMed ID: 17761106 [No Abstract] [Full Text] [Related]
17. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study. Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072 [TBL] [Abstract][Full Text] [Related]
18. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen. Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565 [TBL] [Abstract][Full Text] [Related]
19. How to stop the allergy march. Lopes Dos Santos JM Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):39-40. PubMed ID: 17761107 [No Abstract] [Full Text] [Related]